B of A Securities Maintains Buy on Hims & Hers Health, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny maintains a Buy rating on Hims & Hers Health (NYSE:HIMS) and raises the price target from $22 to $26.
June 13, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities analyst Michael Cherny maintains a Buy rating on Hims & Hers Health and raises the price target from $22 to $26.
The Buy rating and increased price target from a reputable analyst at B of A Securities is likely to positively impact investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100